Best Medical Stocks To Watch Right Now

Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

Investors who wish to attend the event should contact David Scher at or visit for more information.

Best Medical Stocks To Watch Right Now: Transocean Inc.(RIG)

Advisors’ Opinion:

  • [By The Ticker Tape]

    TD Ameritrade clients appeared to take some profits in multiple names during the period. Oil companies were popular sells with ConocoPhillips (NYSE: COP), BP  PLC (ADR) (NYSE: BP), National-Oilwell Varco Inc. (NYSE: NOV), and Transocean LTD (NYSE: RIG) all net sold. Oil prices traded near three-year highs on higher global demand and possible OPEC-led production cuts. COP and BP both traded at multi-year highs, while NOV and RIG reached 52-week highs, enticing clients to take profits in all four names. Alcoa Corp. (NYSE: AA) traded at levels not seen since before the financial crisis following proposed tariffs on steel and aluminum, and was net sold. For the third month in a row, Facebook, Inc. (NASDAQ: FB) was net sold after CEO Mark Zuckerberg testified before Congress regarding the misuse of user data and a beat on earnings.

  • [By Ethan Ryder]

    D.B. Root & Company LLC acquired a new position in shares of Transocean (NYSE:RIG) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 30,040 shares of the offshore drilling services provider’s stock, valued at approximately $297,000.

  • [By Max Byerly]

    ValuEngine upgraded shares of Transocean (NYSE:RIG) from a hold rating to a buy rating in a research note released on Wednesday morning.

    Several other research firms have also recently issued reports on RIG. Bank of America increased their price objective on Transocean from $12.00 to $13.00 and gave the stock a neutral rating in a research report on Wednesday, April 18th. Citigroup increased their price objective on Transocean from $15.00 to $16.00 and gave the stock a buy rating in a research report on Monday, April 30th. Susquehanna Bancshares set a $11.00 price objective on Transocean and gave the stock a hold rating in a research report on Friday, January 12th. Cowen set a $11.00 price objective on Transocean and gave the stock a hold rating in a research report on Thursday, January 11th. Finally, Piper Jaffray set a $11.00 price objective on Transocean and gave the stock a hold rating in a research report on Wednesday, January 10th. Eight investment analysts have rated the stock with a sell rating, ten have given a hold rating and fourteen have issued a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $11.79.

  • [By Spencer Israel]

    Oil companies were popular sells for the month, including ConocoPhillips (NYSE: COP), BP p.l.c. (NYSE: BP), and Transocean Ltd. (NYSE: RIG) all net sold. Investors also net sold Alcoa Corp. (NYSE: AA), Starbucks Corporation (NYSE: CMG). and Facebook Inc. (NASDAQ: FB) in the midst of CEO Mark Zuckerberg's testimony before Congress. 

Best Medical Stocks To Watch Right Now: (LVMUY)

Advisors’ Opinion:

  • [By ]

    French luxury house LVMH SE (LVMUY) stock surged 3.55% in Paris, changing hands at 278.8 after it reported better-than-expected first quarter sales. Organic revenues rose by 13% in the first three months of the year, driven by its fashion and leather goods division.

  • [By ]

    Two years ago, I discussed LVMH (OTCPK:LVMUY) (OTCPK:LVMHF) in another article here on Seeking Alpha. Although I wasnt too impressed with the companys free cash flow yield, I did agree this company deserved a premium valuation. And on top of that, I was expecting its strong growth results to continue in the years ahead. Were now two years later, and LVMH has delivered on every front. Unfortunately the market caught up on that as well, and LVMHs share price has doubled in just two years. And although the LVMH results justify a good performance of the share price, I do think LVMH is getting a little pricey.

Best Medical Stocks To Watch Right Now: Pan American Silver Corp.(PAAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Pan American Silver (NASDAQ:PAAS) (TSE:PAAS) shares shot up 0.7% on Friday . The stock traded as high as $18.39 and last traded at $18.17. 97,207 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 1,076,284 shares. The stock had previously closed at $18.29.

Best Medical Stocks To Watch Right Now: Cardiome Pharma Corporation(CRME)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cardiome Pharma Corp. (NASDAQ: CRME) is expected to post quarterly loss at $0.07 per share on revenue of $6.34 million.

    Quest Resource Holding Corporation (NASDAQ: QRHC) is estimated to post quarterly loss at $0.09 per share on revenue of $24.85 million.

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern’s rankings:

    Get Cardiome Pharma alerts:

    Cardiome Pharma Corp (TSE:COM): Should The Recent Earnings Drop Worry You? ( Pacira Pharmaceuticals Gets a Hold Rating from Canaccord Genuity ( As of May, 21 Analysts See $-0.20 EPS for Cardiome Pharma Corp. (CRME) ( Cardiome Pharma Corp. (CRME) stock added 0.33% off its SMA-20 ( Cardiome Pharma (CRME) Upgraded to Sell at ValuEngine (

    Shares of CRME traded down $0.01 during mid-day trading on Wednesday, reaching $2.29. The company’s stock had a trading volume of 730 shares, compared to its average volume of 138,610. The firm has a market cap of $80.20 million, a price-to-earnings ratio of -2.53 and a beta of 0.19. The company has a debt-to-equity ratio of 2.47, a quick ratio of 3.99 and a current ratio of 4.80. Cardiome Pharma has a 52 week low of $2.28 and a 52 week high of $2.30.

Best Medical Stocks To Watch Right Now: Stewart Information Services Corporation(STC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    StarChain (CURRENCY:STC) traded 8.7% lower against the US dollar during the 24-hour period ending at 20:00 PM E.T. on May 14th. StarChain has a market cap of $0.00 and approximately $5.27 million worth of StarChain was traded on exchanges in the last 24 hours. One StarChain token can now be purchased for about $0.0925 or 0.00001062 BTC on major cryptocurrency exchanges. During the last seven days, StarChain has traded down 16.3% against the US dollar.

Best Medical Stocks To Watch Right Now: Kingtone Wirelessinfo Solution Holding Ltd(KONE)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.